• BioNTech CEO Ugur Sahin sold 64,000 ordinary shares on Sept. 17-18, 2026 at USD 96.22 to USD 98.6.
• Direct holdings fell to 489,209 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNTech SE published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002123975-26-000019), on September 18, 2026, and is solely responsible for the information contained therein.